{
    "Trade/Device Name(s)": [
        "ARCHITECT Sirolimus Assay",
        "ARCHITECT Sirolimus Calibrators"
    ],
    "Submitter Information": "Fujirebio Diagnostics, Inc.",
    "510(k) Number": "K070822",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042411"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NRP",
        "DLJ",
        "JIT"
    ],
    "Summary Letter Date": "September 28, 2007",
    "Summary Letter Received Date": "September 17, 2007",
    "Submission Date": "September 14, 2007",
    "Regulation Number(s)": [
        "21 CFR 862.3840",
        "21 CFR 862.3200"
    ],
    "Regulation Name(s)": [
        "Sirolimus test system"
    ],
    "Analyte Class(es)": [
        "tdm",
        "transplant"
    ],
    "Analyte(s)": [
        "Sirolimus"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Transplant Pretreatment Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)",
        "Manual extraction",
        "Precipitation",
        "Centrifugation"
    ],
    "Methodologies": [
        "Immunoassay",
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT Sirolimus Assay and Calibrators for quantitative sirolimus measurement in whole blood using CMIA on ARCHITECT i System.",
    "Indications for Use Summary": "Quantitative determination of sirolimus in human whole blood as an aid in the management of renal transplant patients receiving sirolimus therapy.",
    "fda_folder": "Toxicology"
}